The DiMPA Network, a group of private OB/GYNs and general practitioners trained to provide quality family planning services in in 45 cities of India, including Uttar Pradesh, Uttarakhand and Jharkhand is seeking a crisis management and media tracking PR firm for an initial period of January 2016– September 2016.
The project focuses on providing the Depot Medroxyprogesterone Acetate (DMPA) 3-month injectable contraceptive and is co-funded by Gates Foundation and Packard Foundation. The project aims to improve the choices for women in these states to plan the number and timing of their children by increasing knowledge of, access to and use of an expanded basket of contraceptives including injectable contraceptives. In India, DMPA has a history of controversies. It has been opposed by women’s groups largely based on three arguments:
- Concern about adverse health consequences
- Lack of credibility of post marketing surveillance of Depo Provera
- Feasibility of ensuring quality in service delivery to counsel & manage side-effects and follow-up
